Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
22230 | 389 | 38.3 | 93% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
10 | 3 | IMMUNOLOGY//JOURNAL OF IMMUNOLOGY//IMMUNOL | 134299 |
854 | 2 | CD40//BAFF//CD40 LIGAND | 11643 |
22230 | 1 | DCR3//DECOY RECEPTOR 3//TL1A | 389 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | DCR3 | authKW | 3194184 | 12% | 88% | 46 |
2 | DECOY RECEPTOR 3 | authKW | 2009492 | 8% | 80% | 32 |
3 | TL1A | authKW | 1635331 | 6% | 83% | 25 |
4 | DEATH RECEPTOR 3 | authKW | 386437 | 2% | 62% | 8 |
5 | VASCULAR ENDOTHELIAL GROWTH INHIBITOR | authKW | 386437 | 2% | 62% | 8 |
6 | DR3 | authKW | 379008 | 3% | 37% | 13 |
7 | VEGI | authKW | 358833 | 2% | 57% | 8 |
8 | DECOY RECEPTOR 3 DCR3 | authKW | 353230 | 2% | 75% | 6 |
9 | TNFSF15 | authKW | 316588 | 3% | 37% | 11 |
10 | DEATH DECOY RECEPTOR 3 | authKW | 235489 | 1% | 100% | 3 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Immunology | 1401 | 30% | 0% | 115 |
2 | Oncology | 404 | 18% | 0% | 71 |
3 | Cell Biology | 251 | 15% | 0% | 57 |
4 | Rheumatology | 223 | 5% | 0% | 18 |
5 | Medicine, Research & Experimental | 214 | 10% | 0% | 38 |
6 | Pathology | 149 | 6% | 0% | 24 |
7 | Biochemistry & Molecular Biology | 144 | 20% | 0% | 77 |
8 | Gastroenterology & Hepatology | 113 | 6% | 0% | 23 |
9 | Biophysics | 26 | 4% | 0% | 16 |
10 | Hematology | 16 | 3% | 0% | 11 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | IMMUNOBIOL DRUG DISCOVERY | 156993 | 1% | 100% | 2 |
2 | HEADQUARTERS PBC NHOSLJ | 104660 | 1% | 67% | 2 |
3 | CIBER EHD IDIB S | 78496 | 0% | 100% | 1 |
4 | GASTROENTEROLLAIKO HOSP | 78496 | 0% | 100% | 1 |
5 | GI DI PROPAEDEUT INTERNAL MED 1 | 78496 | 0% | 100% | 1 |
6 | IMMUNOL HOSP | 78496 | 0% | 100% | 1 |
7 | INFECT DISLAIKO HOSP INTERNAL MED 1 | 78496 | 0% | 100% | 1 |
8 | INVEST BIOMED REDSOBRE ENFRMEDADES NEURODEGEN | 78496 | 0% | 100% | 1 |
9 | PRED INFLAMMAT DISCOVERY THER EUT AREA | 78496 | 0% | 100% | 1 |
10 | PRED ROCHE DIAGNOST GMBH | 78496 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | MUCOSAL IMMUNOLOGY | 3552 | 2% | 1% | 6 |
2 | PIMA MAGAZINE | 2377 | 0% | 3% | 1 |
3 | CYTOKINE | 1763 | 3% | 0% | 10 |
4 | ANGIOGENESIS | 1704 | 0% | 2% | 1 |
5 | INFLAMMATORY BOWEL DISEASES | 1078 | 1% | 0% | 3 |
6 | JOURNAL OF IMMUNOLOGY | 887 | 6% | 0% | 25 |
7 | INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY | 879 | 2% | 0% | 8 |
8 | NATO ADVANCED SCIENCE INSTITUTES SERIES, SERIES A, LIFE SCIENCES | 871 | 1% | 1% | 2 |
9 | CLINICAL IMMUNOLOGY | 726 | 1% | 0% | 5 |
10 | DARU-JOURNAL OF FACULTY OF PHARMACY | 658 | 0% | 1% | 1 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | DCR3 | 3194184 | 12% | 88% | 46 | Search DCR3 | Search DCR3 |
2 | DECOY RECEPTOR 3 | 2009492 | 8% | 80% | 32 | Search DECOY+RECEPTOR+3 | Search DECOY+RECEPTOR+3 |
3 | TL1A | 1635331 | 6% | 83% | 25 | Search TL1A | Search TL1A |
4 | DEATH RECEPTOR 3 | 386437 | 2% | 62% | 8 | Search DEATH+RECEPTOR+3 | Search DEATH+RECEPTOR+3 |
5 | VASCULAR ENDOTHELIAL GROWTH INHIBITOR | 386437 | 2% | 62% | 8 | Search VASCULAR+ENDOTHELIAL+GROWTH+INHIBITOR | Search VASCULAR+ENDOTHELIAL+GROWTH+INHIBITOR |
6 | DR3 | 379008 | 3% | 37% | 13 | Search DR3 | Search DR3 |
7 | VEGI | 358833 | 2% | 57% | 8 | Search VEGI | Search VEGI |
8 | DECOY RECEPTOR 3 DCR3 | 353230 | 2% | 75% | 6 | Search DECOY+RECEPTOR+3+DCR3 | Search DECOY+RECEPTOR+3+DCR3 |
9 | TNFSF15 | 316588 | 3% | 37% | 11 | Search TNFSF15 | Search TNFSF15 |
10 | DEATH DECOY RECEPTOR 3 | 235489 | 1% | 100% | 3 | Search DEATH+DECOY+RECEPTOR+3 | Search DEATH+DECOY+RECEPTOR+3 |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | SIAKAVELLAS, SI , SFIKAKIS, PP , BAMIAS, G , (2015) THE TL1A/DR3/DCR3 PATHWAY IN AUTOIMMUNE RHEUMATIC DISEASES.SEMINARS IN ARTHRITIS AND RHEUMATISM. VOL. 45. ISSUE 1. P. 1 -8 | 67 | 89% | 4 |
2 | RICHARD, AC , FERDINAND, JR , MEYLAN, F , HAYES, ET , GABAY, O , SIEGEL, RM , (2015) THE TNF-FAMILY CYTOKINE TL1A: FROM LYMPHOCYTE COSTIMULATOR TO DISEASE CO-CONSPIRATOR.JOURNAL OF LEUKOCYTE BIOLOGY. VOL. 98. ISSUE 3. P. 333 -345 | 74 | 61% | 6 |
3 | SIAKAVELLAS, SI , BAMIAS, G , (2015) TUMOR NECROSIS FACTOR-LIKE CYTOKINE TL1A AND ITS RECEPTORS DR3 AND DCR3: IMPORTANT NEW FACTORS IN MUCOSAL HOMEOSTASIS AND INFLAMMATION.INFLAMMATORY BOWEL DISEASES. VOL. 21. ISSUE 10. P. 2441 -2452 | 64 | 69% | 2 |
4 | LIN, WW , HSIEH, SL , (2011) DECOY RECEPTOR 3: A PLEIOTROPIC IMMUNOMODULATOR AND BIOMARKER FOR INFLAMMATORY DISEASES, AUTOIMMUNE DISEASES AND CANCER.BIOCHEMICAL PHARMACOLOGY. VOL. 81. ISSUE 7. P. 838-847 | 61 | 64% | 52 |
5 | AIBA, Y , NAKAMURA, M , (2013) THE ROLE OF TL1A AND DR3 IN AUTOIMMUNE AND INFLAMMATORY DISEASES.MEDIATORS OF INFLAMMATION. VOL. . ISSUE . P. - | 58 | 67% | 6 |
6 | TOUGAARD, P , ZERVIDES, KA , SKOV, S , HANSEN, AK , PEDERSEN, AE , (2016) BIOLOGICS BEYOND TNF-ALPHA INHIBITORS AND THE EFFECT OF TARGETING THE HOMOLOGUES TL1A-DR3 PATHWAY IN CHRONIC INFLAMMATORY DISORDERS.IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY. VOL. 38. ISSUE 1. P. 29 -38 | 49 | 64% | 2 |
7 | WANG, ECY , (2012) ON DEATH RECEPTOR 3 AND ITS LIGANDS....IMMUNOLOGY. VOL. 137. ISSUE 1. P. 114-116 | 38 | 86% | 0 |
8 | MEYLAN, F , RICHARD, AC , SIEGEL, RM , (2011) TL1A AND DR3, A TNF FAMILY LIGAND-RECEPTOR PAIR THAT PROMOTES LYMPHOCYTE COSTIMULATION, MUCOSAL HYPERPLASIA, AND AUTOIMMUNE INFLAMMATION.IMMUNOLOGICAL REVIEWS. VOL. 244. ISSUE . P. 188-196 | 36 | 77% | 42 |
9 | CAVALLINI, C , LOVATO, O , BERTOLASO, A , PACELLI, L , ZORATTI, E , ZANOLIN, E , KRAMPERA, M , ZAMO, A , TECCHIO, C , CASSATELLA, MA , ET AL (2013) THE TNF-FAMILY CYTOKINE TL1A INHIBITS PROLIFERATION OF HUMAN ACTIVATED B CELLS.PLOS ONE. VOL. 8. ISSUE 4. P. - | 30 | 88% | 13 |
10 | PERKS, WV , SINGH, RK , JONES, GW , TWOHIG, JP , WILLIAMS, AS , HUMPHREYS, IR , TAYLOR, PR , JONES, SA , WANG, ECY , (2016) DEATH RECEPTOR 3 PROMOTES CHEMOKINE-DIRECTED LEUKOCYTE RECRUITMENT IN ACUTE RESOLVING INFLAMMATION AND IS ESSENTIAL FOR PATHOLOGICAL DEVELOPMENT OF MESOTHELIAL FIBROSIS IN CHRONIC DISEASE.AMERICAN JOURNAL OF PATHOLOGY. VOL. 186. ISSUE 11. P. 2813 -2823 | 38 | 66% | 0 |
Classes with closest relation at Level 1 |
Rank | Class id | link |
---|---|---|
1 | 10449 | LYMPHOTOXIN//BTLA//TERTIARY LYMPHOID ORGANS |
2 | 21324 | TWEAK//FN14//STWEAK |
3 | 24952 | PHARMACEUT PROTE//TNFR2//TNF DEFICIENCY |
4 | 5671 | CROHNS DISEASE//CARD15//ATG16L1 |
5 | 33279 | TIPE2//TNFAIP8//TNFAIP8L2 TIPE2 |
6 | 8384 | 4 1BB//OX40//CD137 |
7 | 1319 | FAS//FAS LIGAND//FASL |
8 | 34857 | LIPOPOLYSACCHARIDE INDUCED TNF ALPHA FACTOR//LITAF//LPS INDUCED TNF ALPHA FACTOR |
9 | 1157 | TRAIL//DR5//TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND |
10 | 17169 | INNATE LYMPHOID CELLS//GROUP 2 INNATE LYMPHOID CELLS//ILC2 |